Impeding U.S. generic drug use criticized

Apr 19, 2006

Moves by branded drug companies to slow the spread of U.S. generic drugs has been criticized by a pharmacy benefit managers' organization.

"There's an agenda to prevent generics from getting to the market as soon as they could," said Mark Merritt, president of the Pharmaceutical Care Management Association.

There are an unprecedented number of top-selling drugs scheduled to go off patent within five years, and the organization said branded drug companies are creating hurdles to potential savings of $23 billion to seniors and the Medicare system.

The association identified 14 drugs commonly used by older people that are set to go off patent by 2010, including the cholesterol drugs Zocor and Pravachol, the antidepressant Zoloft and the prostate medication Proscar.

Under federal legislation passed in 1984, drug makers have 20 years after discovery of a drug to sell it exclusively, but some drug companies are lobbying for longer patent exclusivity.

"Many of the branded companies have pretty empty pipelines, with few big blockbusters on the horizon," Merritt said. "So they're fighting to keep their current big sellers free of competition."

Copyright 2006 by United Press International

Explore further: Marcellus drilling boom may have led to too many hotel rooms

add to favorites email to friend print save as pdf

Related Stories

Rio's Olympic golf course in legal bunker

5 hours ago

The return of golf to the Olympics after what will be 112 years by the time Rio hosts South America's first Games in 2016 comes amid accusations environmental laws were got round to build the facility in ...

Alibaba prices IPO at $68 per share

7 hours ago

Alibaba, the Chinese e-commerce powerhouse named after a fabled, poor woodsman who discovers a thieves' den full of treasures, is ready to strike it rich on the New York Stock Exchange.

Recommended for you

User comments : 0